AVROBIO to merge with Tectonic in all-stock deal; $130.7M private financing; combined company targets GPCRs

Tectonic Therapeutic, Inc.

Pre-merger AVRO holders expected to own ~22.3%; Tectonic holders ~40.2%; financing investors ~37.5% of combined firm.
Concurrent $130.7M private placement from new and existing life sciences investors; combined cash ~$165M at close, runway into mid-2027.
Combined company to advance Tectonic's lead asset TX45 (Fc-relaxin fusion protein) through clinical catalysts.
AVRO stockholders to receive CVRs for contingent payments from future monetization of AVRO's legacy gene therapy assets.
Support agreements from ~88% of Tectonic voting power and ~10.8% of AVRO shares; 180-day lock-up for insiders.

item 1.01 item 5.01 item 5.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Tectonic Therapeutic, Inc. entered into Agreement and Plan of Merger and Reorganization with AVROBIO, Inc. and Alpine Merger Subsidiary, Inc. (effective 2024-01-30).

Action: entry
Agreement: merger
Counterparty: AVROBIO, Inc. and Alpine Merger Subsidiary, Inc.
Effective: 2024-01-30

Exact text from the filing

On January 30, 2024, AVROBIO, Inc., a Delaware corporation (“AVRO”), Alpine Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of AVRO (“Merger Sub”), and Tectonic Therapeutic, Inc., a Delaware corporation (“Tectonic”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”)

View on SEC.gov

800 material agreements filed in the last 30 days. Browse all material agreements →

Tectonic Therapeutic, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-018812

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.